LSD’s Long, Strange Comeback

The 1960s Counter Culture Soured America on Psychedelic Drugs. Now, They’re Returning to Our Laboratories (and Possibly Our Medicine Cabinets).

Brain art

In March 2014, for the first time in over 40 years, a study of the therapeutic benefits of lysergic acid diethylamide—more commonly known as LSD—was published in a peer-reviewed medical journal. The study was conducted in Switzerland (where LSD was first created), and approved by the Swiss Federal Office for Public Health and the U.S. Food and Drug Administration. It showed that LSD-assisted psychotherapy significantly reduced anxiety in individuals with “life-threatening diseases,” including Parkinson’s disease and breast cancer.

This study is part of a recent wave of clinical research on psychedelic …

More In: Who We Were